Table 2.
Gonadal and endocrinological assessment of all patients.
| Sex | Age | LH (mU/ml) | FHS (mU/ml) | E | T (ng/ml) | AMH (mcg/L) | Inhibin B (pg/ml) |
Tanner stage | Hight (SDS) | Weight (SDS) | BMI (SDS) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Patient 1 | M | 12 y 8 m 13 y 6 m 14 y 3 m 15 y |
65,6 29,2 18,9 23,3 |
16,6 55,7 58 54,1 |
2 3,11 3,27 2,18 |
3,96 7,21 3,66 2,9 |
<7 <7 <7 <7 |
A2; P2-3; G2 A3; P3; G3 A3; P4; G4 A3; P5; G4 |
1.01 0.56 0.13 0.25 |
0.83 0.13 -0.52 -0.69 |
0.48 -0.30 -0.88 -0.78 |
|
| Patient 2 | F | 10 y 8 m 11 y 11 y 4 m 12 y 4 m 13 y 8 m |
<0.3 <0.3 <0.3 <0.3 1.1 |
2.7 1.8 3.1 2.8 5.1 |
< 5 14 |
0.83 0.57 0.22 |
A1; B1; P1 A1; B1; P1 A1; B1; P1 A1; B1; P1-2 A2; B2; P3 |
-0.09 -0.06 -0.31 -0.54 0.10 |
-1.39 -1.76 -1.77 -2.16 -1.95 |
-2.07 -2.76 -2.55 -2.87 -2.69 |
||
| Patient 3 | M | 12 y 4 m 13 y 1 m 13 y 8 m 14 y 6 m |
1,5 4,5 6.3 4.7 |
1.8 2.1 3 3.3 |
0,38 1,69 2,93 3,63 |
22.5 7.77 |
161,9 | A2; P2; G2 A2; P2; G2 A3; P3; G3 A3; P3; G3 |
-0.92 0.90 -0.99 -1.13 |
0.87 0.77 1.15 1.03 |
1.59 1.47 1.92 1.83 |
|
| Patient 4 | M | 14 y 14 y 7 m 15 y 3 m 16 |
13.1 12.9 10.3 19.8 |
33.7 32.9 29.2 33.6 |
5.54 4.77 3.78 6.51 |
12.7 11.1 8.29 |
<7 <7 <7 |
A2; P2; G3 A3; P3; G4 A3; P4; G5 A3; P4; G5 |
1.02 0.71 0.57 0.56 |
0.05 -0.50 -0.72 -0.45 |
-0.74 -1.12 -1.37 -0.81 |
|
| Patient 5 | F | 10 y 10 m 11 y 8 m 12 y 1 m |
9.1 7 11.3 |
6.2 10.1 9 |
43 56 |
1.55 1.25 |
A2; B2-3; P2 A2; B3; P3 A3; B3; P3-4 |
0.94 0.73 0.69 |
0.04 -0.34 -0.80 |
-0.53 -0.97 -1.60 |
||
| Patient 6 | F | 3 y 3 m 3 y 9 m |
5.2 3.3 |
44.5 35.3 |
<5 <5 |
<0,01 <0,01 |
A1; B1; P1 A1; B1; P1 |
-3.10 -3.10 |
-3.23 -4.30 |
-1.82 -2.06 |
||
| Patient 7 | F | 8 y 8 m | <0.3 | 1.9 | <5 | 3.62 | A1; B1; P2 | -0.78 | -1.61 | -1.79 | ||
| Patient 8 | F | 9 y 11 m | 24.6 | 37.4 | 0.01 | A1; B1; P1 | -0.73 | -0.95 | -0.83 |
LH, Luteinizing hormone; FSH, Follicle-Stimulating hormone; AMH, Anti- Mullerian hormone; BMI, Body Mass Index; SDS, Standard Deviation Score.